Volume 3, Issue 1 (2021)

Editorial Note

Pages: 1 - 1

Is Neoadjuvant Chemotherapy a Standard Technique Cancer?

Ben Markman*

Mini Review

Pages: 1 - 3

Life-Years and Lockdowns: Estimating the Effects on Covid-19 and Cancer Outcomes from the UK's Response to the Pandemic

Pinar Jenkins, Karol Sikora* and Paul Dolan

DOI: 10.35248/ejco.21.3.003

Commentary

Pages: 1 - 1

Commentary on Treatment of Large Non-Muscle Invasive Bladder Cancer: The Potential Role of Neo-Adjuvant Intravesical Chemotherapy

Marco Raber and Noor Buchholz*

Commentary

Pages: 1 - 1

Informing Decision Making in Older Women with Early-Stage Triple-Negative Breast Cancer: Adjuvant Chemotherapy or Not?

Jennifer A. Crozier and Christopher M. Pezzi*

Research Article

Pages: 1 - 4

Role of Neoadjuvant Chemotherapy in Oral Cavity SCC: A Surgical Oncologists Experience at Tertiary Care Institute

Dhruv Patel*, Elroy Saldanha, Bonny Joseph, Sandeep Ghosh, Vinod Dhakad and Sanjay Desai

DOI: 10.35248/ejco.21.3.004

Volume 3, Issue 2 (2021)

Short Communication

Pages: 1 - 2

Breast Cancer Metastasis Metabolic Mechanisms

Lingling Zhenye

Commentary

Pages: 1 - 1

Information, Perception, and Risk Awareness about Breast Cancer and Its Treatment Outcome among Students at the University of Gondar in Northwest Ethiopia

Kelifa Emiru

Commentary

Pages: 1 - 1

Commentary on: Using Omics to Investigate the Breast Cancer Landscape

Chiara Parsons

Short Communication

Pages: 1 - 2

Metabolic Reprogramming in Triple-Negative Breast Cancer: Covid 19

Paola M Brown

Commentary

Pages: 1 - 1

Breast cancer caused by BRCA1 in a porcine model system

Donning Clark